MedTrace Logo

Feasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum

NCT03649815 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2020-06-04

Study results available
· View outcomes & findings →

Summary

This protocol describes an attempt to capture the development phase of a mobile support for individuals with schizophrenia. The intent is to describe and account for a rigorous development process that will result in the creation of a beta version that would be tested in a randomized trial for effectiveness - to be addressed in a subsequent protocol

Conditions

  • Schizophrenia Spectrum and Other Psychotic Disorders

Interventions

COMBINATION_PRODUCT

App4Independence

The mobile, app-based platform was designed to: * Help prevent social isolation through personalized prompts, scheduling of activities, and connections to a range of resources relevant to social engagement * Enhance hopeful and informed engagement in the recovery process through functions that foster resilience and draw on evidence based strategies to enhance wellness (e.g., personalized affirmations; tip sheets; relaxation exercises) * Encourage and check-in on daily essential activities for patients - addressing memory, attention, and initiation challenges that often occur as a part of this illness * Provide basic health/safety functionality and track level of wellness * Provide an anonymous peer-peer online network for strategy sharing * Provide an ambient sound detector to assist with identifying hallucinations

Sponsors & Collaborators

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Sean Kidd, PhD · Centre for Addiction and Mental Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-18
Primary Completion
2018-05-08
Completion
2018-05-08

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03649815 on ClinicalTrials.gov